Iron Path Capital Names Jake Fitzgerald as New CEO of PureTech Scientific
2024年8月19日 - 10:00PM
ビジネスワイヤ(英語)
Appointment taps industry leader who brings
decades of knowledge to drive continued growth and success
Iron Path Capital (Iron Path), a private equity firm focused on
healthcare and specialty industrials, today announced the
appointment of industry veteran Jake Fitzgerald as Chief Executive
Officer of PureTech Scientific LLC (PureTech), a global leader in
glycolic acid synthesis and technology. PureTech was founded by
Iron Path after acquiring the Glycolic Acid business from The
Chemours Company last August.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240819522920/en/
Iron Path Capital names Jake Fitzgerald
as the new CEO of PureTech Scientific. (Photo: Business Wire)
Fitzgerald most recently served as President of Americas
Packaging at Essentra, where he had been promoted after a five year
tenure as Regional Business Director. Prior to Essentra, Fitzgerald
was Site Manager at Dow Chemical. His previous experience gives him
a wealth of industry knowledge to guide PureTech into the next era
of opportunities and success.
“Jake’s keen understanding of market trends and visionary
leadership are exactly what PureTech needs to continue its
trajectory of success,” said Scott Mraz, co-founder and managing
partner of Iron Path. “We are confident that under his stewardship,
Jake will empower the PureTech team to drive further innovation,
create significant value for customers, and exceed our ambitious
goals of setting new standards in our field.”
Fitzgerald’s appointment underscores Iron Path’s and PureTech’s
shared commitment to innovation in the Life Sciences and Specialty
Chemical industries. Under his leadership, PureTech is poised to
solidify its position as an industry leader, providing ultra-high
purity alpha hydroxy acids across the Life Science and Specialty
chemical sectors.
“I am honored to join PureTech and excited about the journey
ahead. With its strong foundation and commitment to innovation,
PureTech is uniquely positioned to create a safer and healthier
world with glycolic acid science,” said Fitzgerald. “I look forward
to leading the talented team here to drive growth and continue
pushing the boundaries of what’s possible to achieve the company’s
full potential in this next chapter.”
About PureTech Scientific LLC
Headquartered in Belle, West Virginia, PureTech Scientific is
the global leader in organic synthesis of ultra-high purity alpha
hydroxy acids for the Life Sciences and Specialty Chemical
industries, and the sole manufacturer in the Americas. With over 85
years of operating experience and a commitment to reducing our
carbon footprint, we are dedicated to delivering world-class
products, innovations and customer support for a healthier and
safer world.
www.puretechscientific.com
About Iron Path Capital
Iron Path Capital is an operationally focused private equity
firm focused on lower-middle-market investments across the
healthcare and specialty industrial sectors. With offices in
Nashville, TN and Charlottesville, VA, Iron Path Capital supports
its partners with capital, operating expertise, business
development, and industry relationships to achieve significant
scale. Iron Path Capital selects companies with stable cash flows,
superior management teams, strong performance trajectories, and
multiple vectors for growth, both organic and through
consolidation.
Learn more at www.ironpathcapital.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240819522920/en/
Media@ironpathcapital.com